Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Valerio Spuntarelli, Andrea Negro, Michelangelo Luciani, Enrico Bentivegna & Paolo Martelletti. (2021) Eptinezumab for the treatment of migraine. Expert Opinion on Biological Therapy 21:8, pages 999-1011.
Read now
Read now
Andrea Negro & Paolo Martelletti. (2021) Novel synthetic treatment options for migraine. Expert Opinion on Pharmacotherapy 22:7, pages 907-922.
Read now
Read now
Martina Curto, Fabiola Cipolla, Giusy Ylenia Cisale, Matilde Capi, Valerio Spuntarelli, Martina Guglielmetti, Paolo Martelletti & Luana Lionetto. (2020) Profiling lasmiditan as a treatment option for migraine. Expert Opinion on Pharmacotherapy 21:2, pages 147-153.
Read now
Read now
Chiara Lupi, Simona Guerzoni, Andrea Negro & Silvia Benemei. (2019) Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy. Therapeutics and Clinical Risk Management 15, pages 557-569.
Read now
Read now
Luana Lionetto, Martina Curto, Giusy Ylenia Cisale, Matilde Capi, Fabiola Cipolla, Martina Guglielmetti & Paolo Martelletti. (2019) Fremanezumab for the preventive treatment of migraine in adults. Expert Review of Clinical Pharmacology 12:8, pages 741-748.
Read now
Read now
Andrea Negro & Paolo Martelletti. (2019) Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies. Expert Review of Neurotherapeutics 19:8, pages 769-776.
Read now
Read now
Steven L. Dubovsky. (2019) Applications of calcium channel blockers in psychiatry: pharmacokinetic and pharmacodynamic aspects of treatment of bipolar disorder. Expert Opinion on Drug Metabolism & Toxicology 15:1, pages 35-47.
Read now
Read now
Martina Curto, Matilde Capi, Paolo Martelletti & Luana Lionetto. (2019) How do you choose the appropriate migraine pharmacotherapy for an elderly person?. Expert Opinion on Pharmacotherapy 20:1, pages 1-3.
Read now
Read now
Andrea Negro, Angela Koverech & Paolo Martelletti. (2018) Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential. Journal of Pain Research 11, pages 515-526.
Read now
Read now
Abimael González-Hernández, Bruno A. Marichal-Cancino, Antoinette MaassenVanDenBrink & Carlos M. Villalón. (2018) Side effects associated with current and prospective antimigraine pharmacotherapies. Expert Opinion on Drug Metabolism & Toxicology 14:1, pages 25-41.
Read now
Read now
Maria Adele Giamberardino, Giannapia Affaitati, Raffaele Costantini, Francesco Cipollone & Paolo Martelletti. (2017) Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab. Journal of Pain Research 10, pages 2751-2760.
Read now
Read now
Paolo Martelletti. (2017) Acute treatment of migraine: quo vadis?. Expert Opinion on Pharmacotherapy 18:11, pages 1035-1037.
Read now
Read now
Matilde Capi, Fernando de Andrés, Luana Lionetto, Giovanna Gentile, Fabiola Cipolla, Andrea Negro, Marina Borro, Paolo Martelletti & Martina Curto. (2017) Lasmiditan for the treatment of migraine. Expert Opinion on Investigational Drugs 26:2, pages 227-234.
Read now
Read now
Andrea Negro, Martina Curto, Luana Lionetto, Maria Adele Giamberardino & Paolo Martelletti. (2016) Chronic migraine treatment: from OnabotulinumtoxinA onwards. Expert Review of Neurotherapeutics 16:10, pages 1217-1227.
Read now
Read now
Articles from other publishers (15)
Ramesh Boinpally, Abhijeet Jakate, Matthew Butler & Antonia Periclou. (2022) Atogepant and sumatriptan: no clinically relevant drug–drug interactions in a randomized, open-label, crossover trial. Pain Management 12:4, pages 499-508.
Crossref
Crossref
Linda Al-Hassany, Peter J Goadsby, A H Jan Danser & Antoinette MaassenVanDenBrink. (2022) Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions. The Lancet Neurology 21:3, pages 284-294.
Crossref
Crossref
Andrew M. Blumenfeld, Kerry Knievel, Aubrey Manack Adams, Lawrence Severt, Matthew Butler, Hongxin Lai & David W. Dodick. (2021) Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials. Advances in Therapy 39:1, pages 692-705.
Crossref
Crossref
Maria Clara Tonini, Alessandra Fiorencis, Rosario Iannacchero, Mauro Zampolini, Antonietta Cappuccio, Raffaella Raddino, Elisabetta Grillo, Maria Albanese, Gianni Allais, Marco André Bassano, Filippo Brighina, Terenzio Carboni, Fabio Frediani, Licia Grazzi, Carmela Mastrandrea, Franca Moschiano, Maria Gabriella Poeta, Angelo Ranieri, Renato Turrini & Maria Giulia Marini. (2021) Narrative Medicine to integrate patients’, caregivers’ and clinicians’ migraine experiences: the DRONE multicentre project. Neurological Sciences 42:12, pages 5277-5288.
Crossref
Crossref
Ping Gu, Cheng Chen, Qian Wu, Changhong Dong, Teng Wang, Qi Wan & Xin Dong. (2021) The Effect and Safety of 5-HT1F Receptor Agonist Lasmiditan on Migraine: A Systematic Review and Meta-Analysis. BioMed Research International 2021, pages 1-14.
Crossref
Crossref
Ivan Urits, Kyle Gress, Karina Charipova, Alec M. Zamarripa, Parth M. Patel, Grace Lassiter, Jai Won Jung, Alan D. Kaye & Omar Viswanath. (2020) Pharmacological options for the treatment of chronic migraine pain. Best Practice & Research Clinical Anaesthesiology 34:3, pages 383-407.
Crossref
Crossref
Max Tsai, Michael Case, Paul Ardayfio, Helen Hochstetler & Darren Wilbraham. (2020) Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol. Clinical Pharmacology in Drug Development 9:5, pages 629-638.
Crossref
Crossref
Marina Borro, Martina Guglielmetti, Maurizio Simmaco, Paolo Martelletti & Giovanna Gentile. (2019) The future of pharmacogenetics in the treatment of migraine. Pharmacogenomics 20:16, pages 1159-1173.
Crossref
Crossref
Theodoros Mavridis, Chrysa Koniari, Nikolaos Fakas & Dimos D. Mitsikostas. (2019) Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies: Adverse Effects. What Do We Really Know? A Literature Review. EMJ Innovations, pages 64-72.
Crossref
Crossref
Andrea Negro & Paolo Martelletti. 2019. Placebos and Nocebos in Headaches. Placebos and Nocebos in Headaches
13
25
.
Leda Marina Pomes, Giovanna Gentile, Maurizio Simmaco, Marina Borro & Paolo Martelletti. (2018) Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine. CNS Drugs 32:6, pages 559-565.
Crossref
Crossref
Anna Ferrari, Carlo Baraldi, Manuela Licata & Cecilia Rustichelli. (2018) Polypharmacy Among Headache Patients: A Cross-Sectional Study. CNS Drugs 32:6, pages 567-578.
Crossref
Crossref
Andrea Negro, Martina Curto, Luana Lionetto, Simona Guerzoni, Luigi Alberto Pini & Paolo Martelletti. (2017) A Critical Evaluation on MOH Current Treatments. Current Treatment Options in Neurology 19:9.
Crossref
Crossref
Matilde Capi, Martina Curto, Luana Lionetto, Fernando de Andrés, Giovanna Gentile, Andrea Negro & Paolo Martelletti. (2016) Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response. Therapeutic Advances in Neurological Disorders 9:5, pages 414-423.
Crossref
Crossref
Koneni V. Sashidhara, L. Ravithej Singh, Dharmendra Choudhary, Ashutosh Arun, Sampa Gupta, Sulekha Adhikary, Gopala Reddy Palnati, Rituraj Konwar & Ritu Trivedi. (2016) Design, synthesis and in vitro evaluation of coumarin–imidazo[1,2-a]pyridine derivatives against cancer induced osteoporosis. RSC Advances 6:83, pages 80037-80048.
Crossref
Crossref